TcLand Expression appoints its Scientific and Medical Advisory Board dedicated to Rheumatology
TcLand Expression SA announced the appointment of key opinion leaders to its Scientific and Medical Advisory Board dedicated to rheumatology.
Chaired by Doctor Pierre Miossec, Professor of Clinical Immunology and Head of the Immunogenetics and Inflammation Department at the Edouard Herriot Hospital of Lyon, France, the board brings together a number of distinguished international experts including Doctor Paul Emery, Head of the Academic Unit of Musculoskeletal Disease at Leeds General Infirmary, UK, Doctor Piet van Riel, Head of the Department of Rheumatology at the University Medical Centre of Nijmegen, The Netherlands, Doctor Sara Marsal, Head of the Rheumatology Research Group at the Vall d’Hebron Hospital, Barcelona, Spain, and Doctor Thierry Lequerré, clinician in the Department of
Rheumatology at the University Hospital of Rouen, France.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
New therapeutic approach identified for kidney disease associated with lupus
Monsanto and Complix sign collaboration to bring new technologies to agriculture
Human Genome Science announces positive results of phase 2 clinical trial of Lymphostat-B in systemic lupus

Researchers decode new antibiotic - Combined attack minimizes resistance development
Japan's Ministry of Health, Labour and Welfare grants approval for Actelion's miglustat for the treatment of Niemann-Pick type C disease

How COVID-19 permanently damages the heart - Research team shows for the first time how the inflammation in COVID 19 alters the smallest vessels in the heart

Embryonic development and cancer cell growth - Embryonic factors for reprograming cancer cells

Chemotherapy or not? - Success in researching most effective methods for cancer therapy

Superdex™ 75 Increase, Superdex 200 Increase, Superose™ 6 Increase | Chromatography systems | Cytiva
